Menu
Login
Home
(current)
Recurring Events
CE Calendar
Evaluations
Enduring Materials
Live Events
CE Applications
Links
Login
Enduring Material
PsO for Primary Care Providers, Pt 1
View Activity Info
Enter Basic User Info
View Content
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
1800 Diagonal Road, Suite 360
Alexandria, VA 22314
General Information
Active Dates
Tuesday, October 25, 2022 - Friday, October 25, 2024
Estimated Completion Time
20 minutes
Conference Host
National Psoriasis Foundation
Conference Location
Virtual Conference Room
Conference Name
Psound Bytes CME Podcast
Provider
National Psoriasis Foundation
Watch this Lecture Remotely
Objectives
Event Objectives
Advance PCP understanding of psoriasis
Presentations and Speakers
Presentation #1
PsO for Primary Care Providers, Pt 1
David Rosmarin, MD
Available Credits/Points
Credit Designation
The National Psoriasis Foundation designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credits
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Description
Hear Dr. David Rosmarin, M.D., MAS, assistant professor at Tufts University School of Medicine, provide an overview of psoriasis for primary care providers.
This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $326,934 with 3 percentage funded by CDC/HHS and $100,000 amount and 12 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This program is supported by educational grants from Amgen, Novartis, Pfizer, and UCB.
Disclosure Statements
Series Disclosures
NPF Staff/Planning Committee, has disclosed no relevant financial relationships with commercial interests.
Event Disclosures
Speakers:
David Rosmarin, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
AbbVie, Abcuro, AltruBio, Arena, Boehringer-Ingelheim, Bristol Meyers Squibb, Celgene, Concert, CSL Behring, Dermavant, Dermira, Incyte, Janssen, Kyowa Kirin, Lilly, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharmaceuticals, UCB, VielaBio - Consulting - Relationship Has Not Ended
AbbVie, Amgen, Bristol Meyers Squibb, Celgene, Dermira, Galderma, Incyte, Janssen, Lilly, Merck, Novartis, Pfizer, and Regeneron Pharmaceuticals Inc - Contracted Research - Relationship Has Not Ended
AbbVie, Amgen, Celgene, Incyte, Janssen, Lilly, Novartis, Pfizer, Regeneron Pharmaceuticals Inc., and Sanofi. - Speaking - Relationship Has Not Ended
Commercial Support
Support for this activity is gratefully acknowledged from Amgen. Support for this activity is gratefully acknowledged from Novartis. Support for this activity is gratefully acknowledged from UCB.
Accreditation Statement
The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Test Information
Percentage of Correct Responses Required to Pass
0 %
Percentage of Responses Required to Submit
100 %
Last Review Date
10/25/2022
Continue to Enduring Material
Powered By
eeds Privacy and Registration Refund Policy
|
eeds Accessibility Statement